BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
29 results:

  • 1. Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition.
    Shi YX; Xu L; Wang X; Zhang KK; Zhang CY; Liu HY; Ding PP; Shi W; Liu ZY
    Phytomedicine; 2024 May; 127():155461. PubMed ID: 38452697
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transforming growth factors β and their signaling pathway in renal cell carcinoma and peritumoral space-transcriptome analysis.
    Kajdaniuk D; Hudy D; Strzelczyk JK; Młynarek K; Słomian S; Potyka A; Szymonik E; Strzelczyk J; Foltyn W; Kos-Kudła B; Marek B
    Clin Transl Oncol; 2024 May; 26(5):1229-1239. PubMed ID: 38085441
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Li L; Yang W; Xu Y; Zhou J; Ma K; Zhang K; Zhuang H; Gong Y; Gong K
    J Immunol Res; 2022; 2022():4946197. PubMed ID: 36313180
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer.
    Kumar S; Prajapati KS; Gupta S
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142489
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrin β1 Promotes Pancreatic Tumor Growth by Upregulating Kindlin-2 and TGF-β Receptor-2.
    Mia MS; Jarajapu Y; Rao R; Mathew S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638957
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/smad2/3 pathway.
    Qin MY; Huang SQ; Zou XQ; Zhong XB; Yang YF; Zhang YT; Mi ZC; Zhang YS; Huang ZG
    J Ethnopharmacol; 2021 Nov; 280():114414. PubMed ID: 34314804
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro.
    Yang MD; Sun Y; Zhou WJ; Xie XZ; Zhou QM; Lu YY; Su SB
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921192
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-
    Shi Q; Wu H; Li Y; Shen L; Tian X; Lin T; Wei G
    Biomed Res Int; 2020; 2020():8039840. PubMed ID: 33282954
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PPM1A suppresses the proliferation and invasiveness of RCC cells via smad2/3 signaling inhibition.
    Hong Y; Gong L; Yu B; Dong Y
    J Recept Signal Transduct Res; 2021 Jun; 41(3):245-254. PubMed ID: 32878540
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study.
    Ergun S; Gunes S; Buyukalpelli R; Aydin O
    Int J Exp Pathol; 2020 Jun; 101(3-4):87-95. PubMed ID: 32496656
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells.
    Corbet C; Bastien E; Santiago de Jesus JP; Dierge E; Martherus R; Vander Linden C; Doix B; Degavre C; Guilbaud C; Petit L; Michiels C; Dessy C; Larondelle Y; Feron O
    Nat Commun; 2020 Jan; 11(1):454. PubMed ID: 31974393
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
    Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
    Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/smad2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting Smad in vitro.
    Zhao B; Liu L; Mao J; Liu K; Fan W; Liu J; Zhang Z; Li Q
    Biomed Pharmacother; 2017 Dec; 96():1036-1044. PubMed ID: 29198924
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
    Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
    Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1.
    Liu Y; Xu Y; Li X; Chen Z
    Mol Med Rep; 2015 Apr; 11(4):2717-22. PubMed ID: 25482028
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
    Jingushi K; Ueda Y; Kitae K; Hase H; Egawa H; Ohshio I; Kawakami R; Kashiwagi Y; Tsukada Y; Kobayashi T; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
    Mol Cancer Res; 2015 Mar; 13(3):565-74. PubMed ID: 25381221
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.